126674-78-0 Usage
General Description
2-amino-3,5-difluorobenzoic acid is a chemical compound with the molecular formula C7H5F2NO2. It is a derivative of benzoic acid, with two fluorine atoms attached to the 3 and 5 positions and an amino group attached to the 2 position. 2-amino-3,5-difluorobenzoic acid is commonly used in the synthesis of pharmaceuticals and agrochemicals, as well as in organic chemistry research. Its unique structure allows it to participate in various chemical reactions and functionalization processes, making it a versatile building block for the creation of new compounds. Additionally, 2-amino-3,5-difluorobenzoic acid has potential applications in the development of novel drugs and materials due to its interesting properties and reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 126674-78-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,6,6,7 and 4 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 126674-78:
(8*1)+(7*2)+(6*6)+(5*6)+(4*7)+(3*4)+(2*7)+(1*8)=150
150 % 10 = 0
So 126674-78-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H5F2NO2/c8-3-1-4(7(11)12)6(10)5(9)2-3/h1-2H,10H2,(H,11,12)
126674-78-0Relevant articles and documents
MACROCYCLIC DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES
-
, (2013/09/26)
The invention relates to compounds of formula (Φ) as further defined herein and to the pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising such compounds and salts, and to the uses thereof. The compounds and salts of the present invention inhibit anaplastic lymphoma kinase (ALK) and/or EML4-ALK and are useful for treating or ameliorating abnormal cell proliferative disorders, such as cancer.
MUSCARINIC ANTAGONISTS
-
Page 18, (2010/02/06)
Amide derivatives of 1,4 di-substituted piperidine compounds of formula (I) or a pharmaceutically acceptable salt, ester or solvate thereof, wherein Q and Q are each -CH=, or one of Q and Q is -CH= and the other is -N=; X is -CH2- or (a); Y and Z are -C(R)=, or one of Y and Z is -C(R)= and the other is -N=; R is 1 to 3 substituents selected from H, halogen and alkoxy; R and R are 1 to 3 substituents selected from H, halogen, alkyl and alkoxy; and R and R are H or (C1-C6) alkyl are muscarinic antagonists usuful for treating cognitive disorders such as Alzheimer's disease. Pharmaceutical compositions and methods of preparation are also disclosed.
